Clarksville Pain Institute, LLC
Clarksville Pain Institute, LLC was paid $20K by Medicaid between Jan 2018 and Oct 2018, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 51% of everything it billed.
33Billing provider infoCLARKSVILLE PAIN INSTITUTE, LLC
CLARKSVILLE, TN 37043
CLARKSVILLE, TN 37043
33aNPI1669749537assigned 11/21/2011
33bProvider typePain Management Registered Nurse
28Total paid$20K
24GClaims10,805
24DCodes billed12
24AFirst – last monthJan 2018 – Oct 2018
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,805 | $20K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51% | 1,954 | 1,610 | $10K |
| 96120 | 20% | 1,639 | 1,313 | $4K | |
| 96103 | 13% | 1,638 | 1,312 | $3K | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 13% | 1,401 | 1,168 | $3K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 1.1% | 1,923 | 1,568 | $229.94 |
| 64493 | <1% | 28 | 26 | $187.65 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,943 | 1,586 | $98.94 |
| 64495 | <1% | 28 | 26 | $94.65 | |
| 64494 | <1% | 28 | 26 | $94.65 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 151 | 139 | $0.47 |
| 81025 | 0% | 14 | 13 | $0.00 | |
| 99408 | 0% | 58 | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOX, DEBBIE (OWNER)